DNAJC2
gene geneOn this page
Also known as MPP11MPHOSPH11ZUO1zuotin
Summary
DNAJC2 (DnaJ heat shock protein family (Hsp40) member C2, HGNC:13192) is a protein-coding gene on chromosome 7q22.1, encoding DnaJ homolog subfamily C member 2 (Q99543). Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus.
This gene is a member of the M-phase phosphoprotein (MPP) family. The gene encodes a phosphoprotein with a J domain and a Myb DNA-binding domain which localizes to both the nucleus and the cytosol. The protein is capable of forming a heterodimeric complex that associates with ribosomes, acting as a molecular chaperone for nascent polypeptide chains as they exit the ribosome. This protein was identified as a leukemia-associated antigen and expression of the gene is upregulated in leukemic blasts. Also, chromosomal aberrations involving this gene are associated with primary head and neck squamous cell tumors. This gene has a pseudogene on chromosome 6. Alternatively spliced variants which encode different protein isoforms have been described.
Source: NCBI Gene 27000 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_014377
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13192 |
| Approved symbol | DNAJC2 |
| Name | DnaJ heat shock protein family (Hsp40) member C2 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MPP11, MPHOSPH11, ZUO1, zuotin |
| Ensembl gene | ENSG00000105821 |
| Ensembl biotype | protein_coding |
| OMIM | 605502 |
| Entrez | 27000 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 6 protein_coding, 5 retained_intron, 1 nonsense_mediated_decay
ENST00000249270, ENST00000379257, ENST00000379263, ENST00000412522, ENST00000426036, ENST00000454277, ENST00000464253, ENST00000475065, ENST00000475090, ENST00000483637, ENST00000492497, ENST00000915316
RefSeq mRNA: 4 — MANE Select: NM_014377
NM_001129887, NM_001362667, NM_001362668, NM_014377
CCDS: CCDS43628, CCDS47679
Canonical transcript exons
ENST00000379263 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000881669 | 103341764 | 103341954 |
| ENSE00001530457 | 103344559 | 103344767 |
| ENSE00001600304 | 103322511 | 103322632 |
| ENSE00001628196 | 103322703 | 103322794 |
| ENSE00003460086 | 103326543 | 103326684 |
| ENSE00003464847 | 103312289 | 103312643 |
| ENSE00003497042 | 103315988 | 103316088 |
| ENSE00003500195 | 103316830 | 103317014 |
| ENSE00003501070 | 103327656 | 103327754 |
| ENSE00003594972 | 103337736 | 103337811 |
| ENSE00003613992 | 103323598 | 103323663 |
| ENSE00003625802 | 103312947 | 103313101 |
| ENSE00003628578 | 103315764 | 103315871 |
| ENSE00003650531 | 103321932 | 103322081 |
| ENSE00003656999 | 103319609 | 103319678 |
| ENSE00003671914 | 103319756 | 103319844 |
| ENSE00003686219 | 103324482 | 103324562 |
Expression profiles
Bgee: expression breadth ubiquitous, 296 present calls, max score 96.10.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 29.4374 / max 383.0341, expressed in 1819 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 85375 | 27.6253 | 1817 |
| 85376 | 1.8121 | 944 |
Top tissues by expression
297 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 96.10 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 94.33 | gold quality |
| gluteal muscle | UBERON:0002000 | 93.92 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 93.77 | gold quality |
| cartilage tissue | UBERON:0002418 | 93.47 | gold quality |
| hair follicle | UBERON:0002073 | 93.45 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 93.43 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 93.38 | gold quality |
| tendon | UBERON:0000043 | 93.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.90 | gold quality |
| cervix epithelium | UBERON:0004801 | 92.42 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.39 | gold quality |
| sperm | CL:0000019 | 92.24 | gold quality |
| monocyte | CL:0000576 | 92.05 | gold quality |
| mononuclear cell | CL:0000842 | 92.03 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.02 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.00 | gold quality |
| superficial temporal artery | UBERON:0001614 | 92.00 | gold quality |
| male germ cell | CL:0000015 | 91.99 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.96 | gold quality |
| left testis | UBERON:0004533 | 91.89 | gold quality |
| testis | UBERON:0000473 | 91.84 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 91.79 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 91.78 | gold quality |
| gastrocnemius | UBERON:0001388 | 91.55 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 91.45 | gold quality |
| leukocyte | CL:0000738 | 91.44 | gold quality |
| oviduct epithelium | UBERON:0004804 | 91.36 | gold quality |
| colonic epithelium | UBERON:0000397 | 91.29 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.28 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7606 | no | 1175.72 |
| E-MTAB-11011 | no | 229.98 |
| E-MTAB-6386 | no | 142.11 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| PRC1 |
Literature-anchored findings (GeneRIF, showing 16)
- concluded that Mpp11, an ortholog of yeast Zuo, is a ribosome-associated J protein; proposed that in metazoans, ribosome-associated Zuo and Mpp11 orthologs recruit cytosolic Hsc70 to short ribosome-bound nascent chains as they exit the ribosome (PMID:15802566)
- MPP11 is localized to the cytosol and with Hsp70L1, forms the mammalian ribosome-associated complex. (PMID:16002468)
- describe a novel epitope derived from the MPP11 antigen that has been recognized by human CD8+ CTL (PMID:20231810)
- At the onset of differentiation, ZRF1 specifically displaces polycomb-repressive complex 1 (PRC1) from chromatin and facilitates transcriptional activation (PMID:21179169)
- the majority of AML patients elicited a humoral immune response against the tumor antigen MPP11 (PMID:22433847)
- ZRF1 regulates the INK4-ARF locus during cellular proliferation and senescence, and alterations in ZRF1 may contribute to tumorigenesis. (PMID:22733129)
- our data reveal that ZRF1 is a key transcriptional regulator in leukemia progression (PMID:24292673)
- Zrf1 plays an essential role in neural progenitor cell generation and maintenance (PMID:24449271)
- Zrf1 is transcriptional regulator of neural fate downstream of Id1 in embryonic stem cells.During embryonic stem cell differentiation, Id1 levels decrease allowing Zrf1 to activate neural genes. (PMID:25361733)
- ZRF1 mediates remodeling of this E3 ligase complex directly at the DNA lesion site. (PMID:27091446)
- Unexplored functions of ZRF1-mediated remodeling in replication and double strand break repair are discussed. (PMID:27599465)
- The antibody response to ZRF1 was higher in sera of patients with invasive ductal carcinoma than in sera of patients with other histological types of breast tumors. (PMID:27847402)
- In response to UV irradiation, DICER is recruited to chromatin in a ZRF1-mediated manner. The H2A-ubiquitin binding protein ZRF1 and DICER together impact on the chromatin conformation via PARP1. (PMID:28402505)
- These findings suggest that ZRF1 plays a crucial role in tumor malignant potential through its overexpression and highlight its usefulness as a prognostic factor and potential therapeutic target in gastric cancer (PMID:29228320)
- DNAJC2 is reversely regulated by miR6273p, promoting the proliferation of colorectal cancer. (PMID:34165158)
- p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation. (PMID:34579723)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dnajc2 | ENSDARG00000070477 |
| mus_musculus | Dnajc2 | ENSMUSG00000029014 |
| rattus_norvegicus | Dnajc2 | ENSRNOG00000012392 |
| drosophila_melanogaster | CG10565 | FBGN0037051 |
| drosophila_melanogaster | l(3)80Fg | FBGN0287183 |
| caenorhabditis_elegans | WBGENE00001020 | |
| caenorhabditis_elegans | WBGENE00001025 | |
| caenorhabditis_elegans | WBGENE00001026 | |
| caenorhabditis_elegans | WBGENE00001029 | |
| caenorhabditis_elegans | dnj-28 | WBGENE00001046 |
| caenorhabditis_elegans | WBGENE00008122 |
Paralogs (20): DNAJC11 (ENSG00000007923), DNAJC25 (ENSG00000059769), DNAJC10 (ENSG00000077232), DNAJC5 (ENSG00000101152), DNAJC3 (ENSG00000102580), DNAJC17 (ENSG00000104129), DNAJC12 (ENSG00000108176), DNAJC4 (ENSG00000110011), DNAJC16 (ENSG00000116138), DNAJC14 (ENSG00000135392), DNAJC1 (ENSG00000136770), DNAJC13 (ENSG00000138246), DNAJC5B (ENSG00000147570), DNAJC5G (ENSG00000163793), DNAJC7 (ENSG00000168259), DNAJC21 (ENSG00000168724), DNAJC18 (ENSG00000170464), DNAJC24 (ENSG00000170946), DNAJC30 (ENSG00000176410), DNAJC9 (ENSG00000213551)
Protein
Protein identifiers
DnaJ homolog subfamily C member 2 — Q99543 (reviewed: Q99543)
Alternative names: M-phase phosphoprotein 11, Zuotin-related factor 1
All UniProt accessions (5): Q99543, C9IZ83, F2Z3H0, F2Z3N9, H7C3L7
UniProt curated annotations — full annotation on UniProt →
Function. Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus. When cytosolic, acts as a molecular chaperone: component of the ribosome-associated complex (RAC), a complex involved in folding or maintaining nascent polypeptides in a folding-competent state. In the RAC complex, stimulates the ATPase activity of the ribosome-associated pool of Hsp70-type chaperones HSPA14 that bind to the nascent polypeptide chain. When nuclear, mediates the switching from polycomb-repressed genes to an active state: specifically recruited at histone H2A ubiquitinated at ‘Lys-119’ (H2AK119ub), and promotes the displacement of the polycomb PRC1 complex from chromatin, thereby facilitating transcription activation.
Subunit / interactions. Component of ribosome-associated complex (RAC), a heterodimer composed of Hsp70/DnaK-type chaperone HSPA14 and Hsp40/DnaJ-type chaperone DNAJC2. Interacts (via ZRF1-UBD region) with ID1.
Subcellular location. Nucleus. Cytoplasm. Cytosol.
Tissue specificity. Widely expressed.
Post-translational modifications. Phosphorylated in M (mitotic) phase.
Domain organisation. The ZRF1-UBD region specifically recognizes and binds H2AK119ub. The ZRF1-UBD region is also involved in protein-protein interactions with other proteins, suggesting that it may be masked by some regulator, thereby preventing its association with H2AK119ub.
Induction. Expression is repressed by CEBPA. Strongly overexpressed in leukemic cells.
Miscellaneous. Constitutes a myeloid leukemia-associated antigen and might be a target for leukemia T-cell therapy.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q99543-1 | 1 | yes |
| Q99543-2 | 2 |
RefSeq proteins (4): NP_001123359, NP_001349596, NP_001349597, NP_055192* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001005 | SANT/Myb | Domain |
| IPR001623 | DnaJ_domain | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017884 | SANT_dom | Domain |
| IPR017930 | Myb_dom | Domain |
| IPR018253 | DnaJ_domain_CS | Conserved_site |
| IPR032003 | RAC_head | Domain |
| IPR036869 | J_dom_sf | Homologous_superfamily |
| IPR042569 | RAC_head_sf | Homologous_superfamily |
| IPR044634 | Zuotin/DnaJC2 | Family |
| IPR054076 | ZUO1-like_ZHD | Domain |
Pfam: PF00226, PF16717, PF21884, PF23082
UniProt features (28 total): helix 7, modified residue 5, region of interest 4, sequence conflict 3, domain 3, chain 2, initiator methionine 1, splice variant 1, mutagenesis site 1, turn 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2M2E | SOLUTION NMR | |
| 6CGH | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99543-F1 | 85.51 | 0.56 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (5): 1, 47, 49, 60, 63
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 512–513 | loss of function. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-3371453 | Regulation of HSF1-mediated heat shock response |
MSigDB gene sets: 173 (showing top):
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT, PUJANA_CHEK2_PCC_NETWORK, GOBP_PROTEIN_MATURATION, ONKEN_UVEAL_MELANOMA_UP, GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS, DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN, GOBP_REGULATION_OF_RESPONSE_TO_STRESS, DER_IFN_BETA_RESPONSE_UP, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, GOBP_PROTEIN_FOLDING, GOBP_DNA_BIOSYNTHETIC_PROCESS, GOBP_CELLULAR_RESPONSE_TO_HEAT, DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS
GO Biological Process (7): DNA replication (GO:0006260), regulation of translational fidelity (GO:0006450), positive regulation of DNA-templated transcription (GO:0045893), ‘de novo’ cotranslational protein folding (GO:0051083), regulation of cellular response to heat (GO:1900034), negative regulation of DNA biosynthetic process (GO:2000279), chromatin organization (GO:0006325)
GO Molecular Function (8): ATPase activator activity (GO:0001671), chromatin binding (GO:0003682), RNA binding (GO:0003723), Hsp70 protein binding (GO:0030544), histone binding (GO:0042393), ribosome binding (GO:0043022), ubiquitin-modified histone reader activity (GO:0061649), protein binding (GO:0005515)
GO Cellular Component (6): nucleus (GO:0005634), nucleoplasm (GO:0005654), nucleolus (GO:0005730), cytoplasm (GO:0005737), cytosol (GO:0005829), nuclear membrane (GO:0031965)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Cellular response to heat stress | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| DNA biosynthetic process | 2 |
| binding | 2 |
| nuclear lumen | 2 |
| DNA metabolic process | 1 |
| regulation of biological quality | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| ‘de novo’ protein folding | 1 |
| cellular response to heat | 1 |
| regulation of cellular response to stress | 1 |
| negative regulation of macromolecule biosynthetic process | 1 |
| negative regulation of DNA metabolic process | 1 |
| regulation of DNA biosynthetic process | 1 |
| cellular component organization | 1 |
| ATP-dependent activity | 1 |
| molecular function activator activity | 1 |
| nucleic acid binding | 1 |
| heat shock protein binding | 1 |
| protein-folding chaperone binding | 1 |
| protein binding | 1 |
| ribonucleoprotein complex binding | 1 |
| ubiquitin-modified protein reader activity | 1 |
| histone reader activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
Protein interactions and networks
STRING
2588 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DNAJC2 | HSPA14 | Q0VDF9 | 982 |
| DNAJC2 | HSPA4 | P34932 | 965 |
| DNAJC2 | DNAJB4 | Q9UDY4 | 854 |
| DNAJC2 | HSPA8 | P11142 | 776 |
| DNAJC2 | DNAJB1 | P25685 | 775 |
| DNAJC2 | RPL31 | P12947 | 726 |
| DNAJC2 | B0YIZ1 | B0YIZ1 | 667 |
| DNAJC2 | ZPR1 | O75312 | 646 |
| DNAJC2 | PDCD11 | Q14690 | 601 |
| DNAJC2 | H2AC20 | Q16777 | 581 |
| DNAJC2 | H2AC19 | P20670 | 575 |
| DNAJC2 | DNAJA1 | P31689 | 571 |
| DNAJC2 | ATP2B4 | P23634 | 566 |
| DNAJC2 | CCNB1 | P14635 | 558 |
| DNAJC2 | DNAJC24 | Q6P3W2 | 557 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DNAJC2 | HSPA14 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HSPA14 | DNAJC2 | psi-mi:“MI:0914”(association) | 0.670 |
| H2AC11 | DNAJC2 | psi-mi:“MI:0915”(physical association) | 0.500 |
| DNAJC2 | H2BC10 | psi-mi:“MI:0915”(physical association) | 0.400 |
| DNAJC2 | ID1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Hspa14 | TDG | psi-mi:“MI:0914”(association) | 0.350 |
| SGTB | ARHGAP32 | psi-mi:“MI:0914”(association) | 0.350 |
| H2AC11 | EED | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRK2 | psi-mi:“MI:0914”(association) | 0.350 | |
| PAK4 | SNRPE | psi-mi:“MI:0914”(association) | 0.350 |
| NEK7 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| rep | UQCRB | psi-mi:“MI:0914”(association) | 0.350 |
| DNAJC2 | RPS3A | psi-mi:“MI:0914”(association) | 0.350 |
| DRG1 | RPS3A | psi-mi:“MI:0914”(association) | 0.350 |
| HSPA14 | SURF6 | psi-mi:“MI:0914”(association) | 0.350 |
| GTF2E2 | STX7 | psi-mi:“MI:0914”(association) | 0.350 |
| PRKY | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| HNRNPCL2 | SMCHD1 | psi-mi:“MI:0914”(association) | 0.350 |
| USP47 | LAMTOR5 | psi-mi:“MI:0914”(association) | 0.350 |
| MTPN | PLCG1 | psi-mi:“MI:0914”(association) | 0.350 |
| SERBP1 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| MND1 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| MILR1 | SBNO1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (285): DDX5 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNAJC2 (Co-fractionation), DNMT1 (Co-fractionation), HSPA14 (Co-fractionation), HSPA4L (Co-fractionation), HYOU1 (Co-fractionation), MYO6 (Co-fractionation), DNAJC2 (Affinity Capture-MS), DNAJC2 (Affinity Capture-MS), DNAJC2 (Affinity Capture-MS)
ESM2 similar proteins: E1C760, E7EXT2, F7AEX0, O00541, O02108, O57476, O94740, P29692, P54103, P79741, P97496, Q16543, Q1RMH9, Q24276, Q24740, Q3B8N8, Q3T095, Q3ZC62, Q4R3D4, Q4R8H2, Q567U6, Q5EAC6, Q5RAS1, Q5RKQ0, Q5ZKI4, Q5ZKM1, Q5ZKY4, Q61081, Q63692, Q640U7, Q68FR9, Q68FU8, Q69ZQ2, Q6AYB3, Q6GQI5, Q6NWJ4, Q6PDG5, Q7TNY6, Q7TQ20, Q7TQK5
Diamond homologs: B8A9B2, F4JVB8, P34454, P54103, Q1A173, Q1G3C4, Q1RMH9, Q4R8H2, Q58FS3, Q6NNN0, Q6NWJ4, Q6P2Y3, Q7TQ20, Q8GW75, Q8LH59, Q8S9H7, Q96KC8, Q99543, Q9FNN6, Q9SIJ5, A0AIS3, A0KMI5, A0Q1R3, A1KR91, A2SIR5, A5EYE5, A6LJ63, A6T4F5, A7Z6W0, A7ZHA5, A7ZVV8, A8FFD1, A9BNG6, A9LZV9, A9MR76, A9MXI3, B1IRF9, B1LFU5, B1XBE0, B1ZUS0
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| DNAJC2 | “form complex” | “Ribosome-associated complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2128 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:103312937:A:C | donor_gain | 1.0000 |
| 7:103315759:TTTA:T | donor_loss | 1.0000 |
| 7:103315760:TTACC:T | donor_loss | 1.0000 |
| 7:103315761:TACC:T | donor_loss | 1.0000 |
| 7:103315762:A:T | donor_loss | 1.0000 |
| 7:103315763:C:CT | donor_loss | 1.0000 |
| 7:103315763:CCTT:C | donor_gain | 1.0000 |
| 7:103315867:AGGGT:A | acceptor_gain | 1.0000 |
| 7:103315868:GGGT:G | acceptor_gain | 1.0000 |
| 7:103315869:GGT:G | acceptor_gain | 1.0000 |
| 7:103315870:GT:G | acceptor_gain | 1.0000 |
| 7:103315872:C:CC | acceptor_gain | 1.0000 |
| 7:103315873:T:G | acceptor_loss | 1.0000 |
| 7:103315879:A:AC | acceptor_gain | 1.0000 |
| 7:103315879:A:C | acceptor_gain | 1.0000 |
| 7:103316045:C:CT | acceptor_gain | 1.0000 |
| 7:103316046:A:T | acceptor_gain | 1.0000 |
| 7:103316907:T:TA | donor_gain | 1.0000 |
| 7:103319603:TATTA:T | donor_loss | 1.0000 |
| 7:103319604:ATTAC:A | donor_loss | 1.0000 |
| 7:103319605:TTACC:T | donor_loss | 1.0000 |
| 7:103319606:TACCT:T | donor_loss | 1.0000 |
| 7:103319607:ACCT:A | donor_loss | 1.0000 |
| 7:103319608:C:CT | donor_loss | 1.0000 |
| 7:103321927:TATAC:T | donor_loss | 1.0000 |
| 7:103321930:A:C | donor_loss | 1.0000 |
| 7:103321931:C:G | donor_loss | 1.0000 |
| 7:103321955:G:A | donor_gain | 1.0000 |
| 7:103321960:T:TA | donor_gain | 1.0000 |
| 7:103322077:CTTTG:C | acceptor_gain | 1.0000 |
AlphaMissense
4130 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:103312639:A:G | L599P | 1.000 |
| 7:103312954:C:G | R595P | 1.000 |
| 7:103312962:G:C | C592W | 1.000 |
| 7:103313007:C:A | W577C | 1.000 |
| 7:103313007:C:G | W577C | 1.000 |
| 7:103313009:A:G | W577R | 1.000 |
| 7:103313009:A:T | W577R | 1.000 |
| 7:103313010:T:A | R576S | 1.000 |
| 7:103313010:T:G | R576S | 1.000 |
| 7:103313045:C:G | A565P | 1.000 |
| 7:103313078:A:G | W554R | 1.000 |
| 7:103313078:A:T | W554R | 1.000 |
| 7:103316020:A:T | V499D | 1.000 |
| 7:103316057:G:C | H487D | 1.000 |
| 7:103316075:C:G | A481P | 1.000 |
| 7:103316077:A:T | I480N | 1.000 |
| 7:103316085:C:A | W477C | 1.000 |
| 7:103316085:C:G | W477C | 1.000 |
| 7:103316086:C:G | W477S | 1.000 |
| 7:103316087:A:G | W477R | 1.000 |
| 7:103316087:A:T | W477R | 1.000 |
| 7:103316088:T:A | R476S | 1.000 |
| 7:103316088:T:G | R476S | 1.000 |
| 7:103316830:C:A | R476I | 1.000 |
| 7:103316830:C:G | R476T | 1.000 |
| 7:103316831:T:C | R476G | 1.000 |
| 7:103316842:C:T | G472E | 1.000 |
| 7:103316843:C:G | G472R | 1.000 |
| 7:103316843:C:T | G472R | 1.000 |
| 7:103316845:G:T | A471D | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000003336 (7:103344183 G>A,C), RS1000267442 (7:103320966 G>C), RS1000273187 (7:103332394 C>T), RS1000442108 (7:103315041 G>A), RS1000465639 (7:103337974 A>C), RS1000498409 (7:103336705 T>C), RS1000514424 (7:103339131 G>A), RS1000638608 (7:103331445 A>G), RS1000784337 (7:103321271 C>T), RS1000907253 (7:103343742 G>A), RS1001033487 (7:103312444 G>A), RS1001157350 (7:103329075 G>A), RS1001202645 (7:103336511 T>C), RS1001212453 (7:103333912 T>C), RS1001283895 (7:103333718 T>A)
Disease associations
OMIM: gene MIM:605502 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_944 | Metabolite levels | 9.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010402 | triacylglycerol 46:2 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
40 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases expression | 2 |
| sodium arsenite | decreases expression, increases activity, affects cotreatment, increases abundance, increases expression | 2 |
| Estradiol | increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| GSK-J4 | increases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| trichostatin A | affects expression | 1 |
| cobaltous chloride | increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2,3,5-(triglutathion-S-yl)hydroquinone | increases ADP-ribosylation | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Ivermectin | decreases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Mustard Gas | increases phosphorylation | 1 |
| Phenobarbital | affects expression | 1 |
| Quercetin | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2W0 | Abcam HEK293T DNAJC2 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.